BMcN,I am hearing this comparison being made around the traps. I have found this broker report which indicates the potential upside for ESN is huge if you look at revenue and earnings going forward.http://mokosocialmedia.com/wp-content/uploads/2013/11/20131112_FS_EquityResearchReport.pdfThe forecasts in this report indicate that MKB is trading on 84x 2014 EPS of .02cps.That's on Revenue of $13m and NPAT of $1.2m!The first hint of revenue/earnings from ESN will validate it's business model and I suggest the price will move accordingly.Hmmmm
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025